Brahmer J, Reckamp KL, Baas P, Crinò L, Eberhardt WEE, Poddubskaya E, et al. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med. 2015;373:123–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rossi G, Russo A, Tagliamento M, Tuzi A, Nigro O, Vallome G, et al. Precision medicine for NSCLC in the era of immunotherapy: new biomarkers to select the most suitable treatment or the most suitable patient. Cancers (Basel). 2020;12:1125.

Article  CAS  PubMed  Google Scholar 

Borghaei H, Paz-Ares L, Horn L, Spigel DR, Steins M, Ready NE, et al. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer. N Engl J Med. 2015;373:1627–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sacher AG, Gandhi L. Biomarkers for the clinical use of PD-1/PD-L1 inhibitors in non-small-cell lung cancer: a review. JAMA Oncol. 2016;2:1217–22.

Article  PubMed  Google Scholar 

Genova C, Boccardo S, Mora M, Rijavec E, Biello F, Rossi G, et al. Correlation between B7–H4 and survival of non-small-cell lung cancer patients treated with nivolumab. J Clin Med. 2019;8:1566.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rijavec E, Coco S, Genova C, Rossi G, Longo L, Grossi F. Liquid biopsy in non-small cell lung cancer: highlights and challenges. Cancers (Basel). 2019;12:17.

Article  PubMed  Google Scholar 

Schwarzenbach H, Gahan PB. MicroRNA shuttle from cell-to-cell by exosomes and its impact in cancer. Noncoding RNA. 2019;5:28.

CAS  PubMed  PubMed Central  Google Scholar 

Halvorsen AR, Sandhu V, Sprauten M, Flote VG, Kure EH, Brustugun OT, et al. Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab. Acta Oncol. 2018;57:1225–31.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Goto Y, Yagishita S, Shinno Y, Mizuno K, Watanabe N, et al. Machine learning-based exceptional response prediction of nivolumab monotherapy with circulating microRNAs in non-small cell lung cancer. Lung Cancer. 2022;173:107–15.

Article  CAS  PubMed  Google Scholar 

Rajakumar T, Horos R, Jehn J, Schenz J, Muley T, Pelea O, et al. A blood-based miRNA signature with prognostic value for overall survival in advanced stage non-small cell lung cancer treated with immunotherapy. NPJ Precis Oncol. 2022;6:19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nik Mohamed Kamal NNSB, Shahidan WNS. Non-exosomal and exosomal circulatory microRNAs: Which are more valid as biomarkers? Front Pharmacol. 2019;10:1500.

Article  PubMed  Google Scholar 

Vanni I, Alama A, Grossi F, Dal Bello MG, Coco S. Exosomes: a new horizon in lung cancer. Drug Discov Today. 2017;22:927–36.

Article  CAS  PubMed  Google Scholar 

Hu Y, Zhang R, Chen G. Exosome and secretion: action on? Adv Exp Med Biol. 2020;1248:455–83.

Article  CAS  PubMed  Google Scholar 

Shukuya T, Ghai V, Amann JM, Okimoto T, Shilo K, Kim T-K, et al. Circulating microRNAs and extracellular vesicle-containing microRNAs as response biomarkers of anti-programmed cell death protein 1 or programmed death-ligand 1 therapy in NSCLC. J Thorac Oncol. 2020;15:1773–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peng X-X, Yu R, Wu X, Wu S-Y, Pi C, Chen Z-H, et al. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer. J Immunother Cancer. 2020;8: e000376.

Article  PubMed  PubMed Central  Google Scholar 

Hisakane K, Seike M, Sugano T, Matsuda K, Kashiwada T, Nakamichi S, et al. Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer. Gene. 2023;857: 147177.

Article  CAS  PubMed  Google Scholar 

Del Re M, Marconcini R, Pasquini G, Rofi E, Vivaldi C, Bloise F, et al. PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC. Br J Cancer. 2018;118:820–4.

Article  PubMed  PubMed Central  Google Scholar 

Ge Q, Zhou Y, Lu J, Bai Y, Xie X, Lu Z. miRNA in plasma exosome is stable under different storage conditions. Molecules. 2014;19:1568–75.

Article  PubMed  PubMed Central  Google Scholar 

Muller L, Hong C-S, Stolz DB, Watkins SC, Whiteside TL. Isolation of biologically-active exosomes from human plasma. J Immunol Methods. 2014;411:55–65.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Enderle D, Spiel A, Coticchia CM, Berghoff E, Mueller R, Schlumpberger M, et al. Characterization of RNA from exosomes and other extracellular vesicles isolated by a novel spin column-based method. PLoS ONE. 2015;10: e0136133.

Article  PubMed  PubMed Central  Google Scholar 

Genova C, Tasso R, Rosa A, Rossi G, Reverberi D, Fontana V, et al. Prognostic role of soluble and extracellular vesicle-associated PD-L1, B7–H3 and B7–H4 in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Cells. 2023;12:832.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coco S, Carenzo A, Savasta FL, Kisakesen I. Exosome miRNA profiling with the agilent miRNA microarray platform.

Vlachos IS, Zagganas K, Paraskevopoulou MD, Georgakilas G, Karagkouni D, Vergoulis T, et al. DIANA-miRPath v3.0: deciphering microRNA function with experimental support. Nucleic Acids Res. 2015;43:W460-466.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Licursi V, Conte F, Fiscon G, Paci P. MIENTURNET: an interactive web tool for microRNA-target enrichment and network-based analysis. BMC Bioinform. 2019;20:545.

Article  Google Scholar 

Dobbin KK, Simon RM. Optimally splitting cases for training and testing high dimensional classifiers. BMC Med Genomics. 2011;4:31.

Article  PubMed  PubMed Central  Google Scholar 

Giallombardo M, Chacártegui Borrás J, Castiglia M, Van Der Steen N, Mertens I, Pauwels P, et al. Exosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients’ plasma through qPCR: a feasible liquid biopsy tool. J Vis Exp. 2016;111:53900.

Google Scholar 

Saito H, Okita K, Fusaki N, Sabel MS, Chang AE, Ito F. Reprogramming of melanoma tumor-infiltrating lymphocytes to induced pluripotent stem cells. Stem Cells Int. 2016;2016:8394960.

Article  PubMed  Google Scholar 

Marconi S, Croce M, Chiorino G, Rossi G, Guana F, Profumo A, et al. A circulating risk score, based on combined expression of exo-miR-130a-3p and fibrinopeptide A, as predictive biomarker of relapse in resectable non-small cell lung cancer patients. Cancers (Basel). 2022;14:3412.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012;13:358–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen C, Tan R, Wong L, Fekete R, Halsey J. Quantitation of microRNAs by real-time RT-qPCR. Methods Mol Biol. 2011;687:113–34.

Article  CAS  PubMed  Google Scholar 

Siddika T, Heinemann IU. Bringing microRNAs to light: methods for microRNA quantification and visualization in live cells. Front Bioeng Biotechnol. 2020;8: 619583.

Article  PubMed